---
title: "Vaccinex files Form 25 to voluntarily withdraw its stock from Nasdaq"
url: "https://aibio.space/news/vaccinex-files-form-25-voluntarily-withdraw-stock-nasdaq/"
publisher: "aibio.space (Biotech Investor Relations News)"
date: "2025-03-17"
section: "Listings"
tickers: "OTC:VCNX"
source: "https://www.sec.gov/Archives/edgar/data/1205922/000119312525055645/d820540d25.htm"
summary: "The Rochester, New York company filed the notice on March 17, 2025. It covers its common stock, par value $0.0001 per share."
---

By the aibio.space news desk.

Sources

- [Vaccinex, Inc. 25 (2025-03-17)](https://www.sec.gov/Archives/edgar/data/1205922/000119312525055645/d820540d25.htm)

[VCNX](https://aibio.space/companies/vaccinex/)

2025-03-17

# Vaccinex files Form 25 to voluntarily withdraw its stock from Nasdaq

Tickers [VCNX](https://aibio.space/companies/vaccinex/)

The Rochester, New York company filed the notice on March 17, 2025. It covers its common stock, par value $0.0001 per share.

## Key facts

- **Company**: Vaccinex, Inc. (OTC: VCNX)

- **News type**: Listings

- **Primary source**: [Vaccinex, Inc. 25 (2025-03-17)](https://www.sec.gov/Archives/edgar/data/1205922/000119312525055645/d820540d25.htm)

*A columned courthouse. Photo: Carol M Highsmith, CC0, via rawpixel. The picture shows the field, not the companies named.*

Vaccinex, Inc. has filed a Form 25 with the Securities and Exchange Commission to remove its common stock from listing on The Nasdaq Stock Market LLC. The notice is dated March 17, 2025.

A Form 25 is the document that ends a security's listing and registration on a national exchange.

In this case Vaccinex checked the box for 17 CFR 240.12d2-2(c), the provision for a voluntary withdrawal by the issuer. The filing states that the company "has complied with the rules of the Exchange" and the requirements of that rule governing the voluntary withdrawal of the class of securities from listing and registration on the exchange. The box for a removal initiated by the exchange under 17 CFR 240.12d2-2(b) was left unchecked.

The class of securities covered is the company's common stock, par value $0.0001 per share. The filing lists the company's principal executive offices at 1895 Mount Hope Avenue in Rochester, New York, and its Commission File Number as 001-38624.

The full notice is available [on the SEC website](https://www.sec.gov/Archives/edgar/data/1205922/000119312525055645/d820540d25.htm).

[Report an error](https://aibio.space/reputation/#correction)

## Companies in this story

VCNX

Vaccinex, Inc.

OTC · United States

Open the starter desk

## More in Listings

Listings

### [Propanc Biopharma faces Nasdaq delisting on bid price, plans to appeal](https://aibio.space/news/propanc-biopharma-faces-nasdaq-delisting-bid-price-plans-appeal/)

Oct 29, 2026

Listings

### [Reviva asks stockholders to approve reverse split of up to 1-for-100](https://aibio.space/news/reviva-asks-stockholders-approve-reverse-split-up-1-100/)

Oct 29, 2026

Listings

### [Nasdaq to delist Glucotrack shares after bid price exception ends](https://aibio.space/news/nasdaq-delist-glucotrack-shares-after-bid-price-exception-ends/)

Oct 28, 2026

---
Source page: https://aibio.space/news/vaccinex-files-form-25-voluntarily-withdraw-stock-nasdaq/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Vaccinex files Form 25 to voluntarily withdraw its stock from Nasdaq", 2025-03-17, https://aibio.space/news/vaccinex-files-form-25-voluntarily-withdraw-stock-nasdaq/